PT24 A quantitative exploration of challenges to the sustainability of the United States biosimilar market
Dayer, V., Roth, J. A., Jofre-Bonet, M., McGuire, A.
& Sullivan, S. D.
(2025).
PT24 A quantitative exploration of challenges to the sustainability of the United States biosimilar market.
Value in Health,
28(6, Supplement 1), S160 - S161.
https://doi.org/10.1016/j.jval.2025.04.2129
& Sullivan, S. D.
(2025).
PT24 A quantitative exploration of challenges to the sustainability of the United States biosimilar market.
Value in Health,
28(6, Supplement 1), S160 - S161.
https://doi.org/10.1016/j.jval.2025.04.2129
Biosimilars have generated significant savings by increasing competition in biologic product markets and driving down prices. These dynamics increase cost-savings in the short-term, but may result in diminished incentives for manufacturers to enter and/or remain in the market. We sought to explore the relationship between market concentration in the U.S. on the price of reference products and biosimilars.